The House on Dec. 2 unanimously passed the Made in America Manufacturing Finance Act, a bipartisan bill that would expand federal loan limits for small manufacturers and aims to bolster domestic supply chain resilience.
The legislation would increase Small Business Administration-backed loan capacity to $10 million for qualifying U.S. manufacturers.
The American Medical Manufacturers Association, which represents domestic producers of critical medical supplies and PPE, said the measure is a strategic investment in supply chain stability. The organization added that the bill would provide capital to upgrade equipment, expand production and reduce reliance on foreign suppliers.
“Every time a U.S. manufacturer can finance a new production line here at home instead of relying on bad actors overseas, American workers, hospitals and first responders are safer and stronger,” association Executive Director Eric Axel said in a Dec. 2 statement shared with Becker’s.
The bill now moves to the Senate, where companion legislation is led by Sens. Joni Ernst, R-Iowa, and Chris Coons, D-Del. The AMMA urged swift passage, calling the expansion of manufacturing loan access essential to reshoring critical supply lines.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
